DEEP PRECISION
Live / Registered — Registered (as of 06 Oct 2026)
What this means for you
Registered since 06 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 98795259
- Registration number
- 8487664
- Mark type
- Word mark
- Filed
- 10 Oct 2024
- Published for opposition
- 27 May 2025
- Registered
- 06 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 06 Oct 2032 (grace period to 06 Apr 2033)
- Attorney of record
- Flavia Campbell
Goods and services
- Class 044 — Medical, beauty and agricultural services: Genetic testing for medical purposes; providing information about genetic testing for medical purposes; providing evidence-based cancer research, trials and information to create treatment plans; Providing information about genetic testing panels by focused cancer type; Providing health information about cancer treatment options based upon data from genetic information panels evaluated by generative AI
Owner
- GeneSilico Inc., Austin, TX, US
- GeneSilico Inc., Austin, TX, US
- GeneSilico Inc., Austin, TX, US
Prosecution history
- 06 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jul 2026 — USE AMENDMENT FILED
- 22 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2026 — SOU EXTENSION 1 GRANTED
- 22 Jan 2026 — SOU EXTENSION 1 FILED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2025 — PUBLISHED FOR OPPOSITION
- 21 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED